Scientist airs fears as SA gears up for GM debate
14 August, 2002 by Melissa TrudingerA gene technology moratorium bill proposed by South Australian Democrat Ian Gilfillan could stifle world-leading research in the state, a leading researcher has warned.
Sirtex opens another treatment centre in the US
13 August, 2002 by Melissa TrudingerSydney biotech Sirtex Medical has opened its fifth US-based cancer treatment centre since the Food and Drug Administration (FDA) approved the company's SIR-Spheres cancer therapy in March.
Norwood patent position grows apace
12 August, 2002 by Melissa TrudingerNorwood Abbey has been issued two more US patents for its proprietary drug delivery platform.
New program to study sheep genomics launched
12 August, 2002 by Melissa TrudingerMeat and Livestock Australia has launched a $15 million sheep genomics project to identify genes and develop tests for immunity to internal parasites and early diagnosis of Ovine Johnes and other diseases, increased efficiency of muscle growth, and improved reproduction.
Big pharma's big commitment
12 August, 2002 by Tanya HollisIn two years' time, a Federal government program credited with encouraging the injection of vital funds into Australian research and development will draw to a close.
Biota in new Hep C partnership with Glaxo
12 August, 2002 by Melissa TrudingerBiota Holdings' US subsidiary Biota Inc has announced a collaboration with GlaxoSmithKline (GSK) to develop new drugs against Hepatitis C, using Biota Inc's proprietary Numax technology platform.
BresaGen wins FDA approval for catheter
08 August, 2002 by Tanya HollisIn a step towards improved application of cell therapies, South Australian company BresaGen has gained US Food and Drug Administration approval to market a catheter designed for the delivery of therapeutics to the brain.
Chemeq raises $8m
07 August, 2002 by Melissa TrudingerChemeq has raised $8 million in its latest placement to institutions and other sophisticated investors, bringing the total raised this year to $15.5 million.
Skin surface laser patent granted to Norwood
07 August, 2002 by Tanya HollisDrug delivery group Norwood Abbey has added another patent to its portfolio, the latest covering laser technology to alter the skin's surface.
Mayne backs new brain centre
07 August, 2002 by Tanya HollisA new Sydney imaging centre is set to improve research opportunities for brain and nervous system specialists.
EQiTX, Starphama appoint heavy hitters
06 August, 2002 by Tanya HollisBorn-again oil exploration company EQiTX has added another science heavyweight to its ranks for its latest incarnation as a biotech.
Aventis CropScience becomes Bayer CropScience
06 August, 2002 by Melissa TrudingerAventis CropScience has officially become Bayer CropScience as a result of last year's acquisition of the CropScience unit by Bayer for around 7.25 billion euros ($AU13.4 billion).
Gradipore's Texan work nears completion
06 August, 2002 by Tanya HollisSydney bioseparations specialist Gradipore has revealed that the first stage of its collaborative work with Texas A&M University is nearing completion.
Prima applies for animal model patent
02 August, 2002 by Tanya HollisInflammatory diseases researcher Arthron has lodged a patent application over an animal model of arthritis with which to test potential new treatments.
pSivida rated 'speculative buy'
02 August, 2002 by Tanya HollisBrokers have rated biomaterials platform technology group pSivida a speculative buy following a recent joint venture with Singapore General Hospital.
